- Home
- NAMS vs PRGO Comparison
NAMS vs PRGO Comparison
Compare NAMS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- PRGO
- Stock Information
- Founded
- NAMS 2019
- PRGO 1887
- Country
- NAMS Netherlands
- PRGO Ireland
- Employees
- NAMS N/A
- PRGO N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- NAMS Health Care
- PRGO Health Care
- Exchange
- NAMS Nasdaq
- PRGO Nasdaq
- Market Cap
- NAMS 3.1B
- PRGO 3.1B
- IPO Year
- NAMS N/A
- PRGO 1991
- Fundamental
- Price
- NAMS $38.74
- PRGO $20.55
- Analyst Decision
- NAMS Strong Buy
- PRGO Buy
- Analyst Count
- NAMS 10
- PRGO 4
- Target Price
- NAMS $43.70
- PRGO $31.25
- AVG Volume (30 Days)
- NAMS 1.3M
- PRGO 1.7M
- Earning Date
- NAMS 11-06-2025
- PRGO 11-05-2025
- Dividend Yield
- NAMS N/A
- PRGO 5.62%
- EPS Growth
- NAMS N/A
- PRGO N/A
- EPS
- NAMS N/A
- PRGO N/A
- Revenue
- NAMS $64,006,000.00
- PRGO $4,326,100,000.00
- Revenue This Year
- NAMS N/A
- PRGO $2.23
- Revenue Next Year
- NAMS N/A
- PRGO $0.54
- P/E Ratio
- NAMS N/A
- PRGO N/A
- Revenue Growth
- NAMS 762.15
- PRGO N/A
- 52 Week Low
- NAMS $14.06
- PRGO $20.44
- 52 Week High
- NAMS $41.47
- PRGO $30.93
- Technical
- Relative Strength Index (RSI)
- NAMS 66.43
- PRGO 35.32
- Support Level
- NAMS $35.50
- PRGO $21.14
- Resistance Level
- NAMS $39.03
- PRGO $22.01
- Average True Range (ATR)
- NAMS 2.30
- PRGO 0.54
- MACD
- NAMS -0.16
- PRGO -0.05
- Stochastic Oscillator
- NAMS 61.67
- PRGO 9.54
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.